National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers

被引：64

作者：

Diamandis, Eleftherios P. ^{[2
,3
]}

Hoffman, Barry R. ^{[2
,3
]}

Sturgeon, Catharine M. ^{[1
]}

机构：

[1] Royal Infirmary Edinburgh, Dept Clin Biochem, Edinburgh, Midlothian, Scotland

[2] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada

[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada

来源：

关键词：

D O I：

10.1373/clinchem.2008.105494

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：1935 / 1939

页数：5

共 15 条

[1] Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[2] Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18
[3] Sources of bias for authors of clinical practice guidelines
Detsky, Allan S.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (09) : 1033 - 1033
[4] Fleisher M, 2002, Tumor markers: physiology, pathobiology, technology, and clinical applications, P33
[5] Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers
Hayes, DF
Bast, RC
Desch, CE
Fritsche, H
Kemeny, NE
Jessup, JM
Locker, GY
MacDonald, JS
Mennel, RG
Norton, L
Ravdin, P
Taube, S
Winn, RJ
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20): : 1456 - 1466
[6] Prognostic and predictive factors for breast cancer: Translating technology to oncology
Hayes, DF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1596 - 1597
[7] Evidence-based guidelines in laboratory medicine: Principles and methods
Oosterhuis, WP
Bruns, DE
Watine, J
Sandberg, S
Horvath, AR
[J]. CLINICAL CHEMISTRY, 2004, 50 (05) : 806 - 818
[8] PENTHEROUDAKIS G, ANN ONCOL UNPUB
[9] PRICE CP, 2007, EVIDENCE BASED LAB
[10] *SIGN, 1998, MANAG ADULT TESTIC